| scholarly article | Q13442814 |
| P2093 | author name string | Holm J | |
| Gabbiani G | |||
| Hansson GK | |||
| Skalli O | |||
| Jonasson L | |||
| P2860 | cites work | Immunological characterization of the subunit of the 100 A filaments from muscle cells | Q24561559 |
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Separation and Functional Analysis of Subpopulations of Lymphocytes Bearing Complement and Fc Receptors | Q34061584 | ||
| The Role of I Region Gene Products in Macrophage - T Lymphocyte Interaction | Q34154351 | ||
| Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G. | Q34203696 | ||
| Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis | Q34207431 | ||
| Arterial foam cells with distinctive immunomorphologic and histochemical features of macrophages | Q35863970 | ||
| The role of cytoskeletal and cytocontractile elements in pathologic processes | Q35885396 | ||
| Is heterogeneous expression of HLA-dr antigens and CEA along with DNA-profile variations evidence of phenotypic instability and clonal proliferation in human large bowel carcinomas? | Q36048208 | ||
| Fc-mediated binding of IgG to vimentin-type intermediate filaments in vascular endothelial cells | Q36261210 | ||
| A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization | Q36270487 | ||
| Heteropolymer filaments of vimentin and desmin in vascular smooth muscle tissue and cultured baby hamster kidney cells demonstrated by chemical crosslinking. | Q36297828 | ||
| Expression of Ia-like antigens by human vascular endothelial cells is inducible in vitro: demonstration by monoclonal antibody binding and immunoprecipitation | Q36319129 | ||
| DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization | Q36341271 | ||
| Ia determinants on human T-cell subsets defined by monoclonal antibody. Activation stimuli required for expression | Q36343167 | ||
| Evolutionary conservation of surface molecules that distinguish T lymphocyte helper/inducer and cytotoxic/suppressor subpopulations in mouse and man | Q36344425 | ||
| Induction of Ia antigen in rat epidermal cells and gut epithelium by immunological stimuli | Q36347142 | ||
| Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon | Q36347669 | ||
| Ia antigens: their serology, molecular relationships, and their role in allograft reactions | Q39393160 | ||
| Distribution of Ia-antigen-like molecules on non-lymphoid tissues | Q39545965 | ||
| Isolation and characterization of detergent-solubilized human HLA-DR transplantation antigens | Q39653981 | ||
| Antigen Presentation by Vascular Endothelial Cells and Epidermal Langerhans Cells: The Role of HLA-DR | Q40113479 | ||
| Mechanism of T cell activation: role and functional relationship of HLA-DR antigens and interleukins | Q40264396 | ||
| Epidermal Langerhans cells express Ia antigens | Q40792241 | ||
| Expression of Ia antigen-like molecules on cells in the corneal epithelium | Q41006225 | ||
| Human Ia-like antigens in non-lymphoid organs | Q41132274 | ||
| Anti-Ia-reactive cells in the urinary tract of man, guinea-pig, rat and mouse | Q41454097 | ||
| Distinct populations of class II molecules identified by monoclonal antibodies | Q43585499 | ||
| Selective Solubilization of a Protein Component of the Red Cell Membrane | Q44742471 | ||
| Hormonal regulation of the expression of Ia antigens on mammary gland epithelium. | Q53956466 | ||
| An improved rosetting assay for detection of human T lymphocytes | Q54517740 | ||
| Vimentin-containing smooth muscle cells in aortic intimal thickening after endothelial injury | Q58439422 | ||
| Distribution of vimentin and desmin filaments in smooth muscle tissue of mammalian and avian aorta | Q58439455 | ||
| Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon | Q59063739 | ||
| Intermediate filaments as mechanical integrators of cellular space | Q59070780 | ||
| Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations | Q66945977 | ||
| Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. I. Resolution of aortic cell populations by metrizamide density gradient centrifugation | Q67658536 | ||
| Expression of Ia-like antigens in normal human nonlymphoid tissues | Q70150646 | ||
| Fc-dependent binding of monocytes to areas with endothelial injury in the rabbit aorta | Q70153163 | ||
| Graft rejection and Ia antigens--paradox resolved? | Q70435273 | ||
| Cytoskeleton of rat aortic smooth muscle cells. Normal conditions and experimental intimal thickening | Q71364565 | ||
| Lipid accumulation in arterial smooth muscle cells. Influence of phenotype | Q71819606 | ||
| Intermediate filaments: cell-type-specific markers in differentiation and pathology | Q71845054 | ||
| Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man | Q72018082 | ||
| HLA-DR-like antigens in the epithelium of the human small intestine | Q72150613 | ||
| Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity | Q72565145 | ||
| Human mononuclear phagocyte differentiation antigens. I. Patterns of antigenic expression on the surface of human monocytes and macrophages defined by monoclonal antibodies | Q72681756 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 125-131 | |
| P577 | publication date | 1985-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis | |
| P478 | volume | 76 |
| Q35816148 | A 90-kd surface antigen from a subpopulation of smooth muscle cells from human atherosclerotic lesions. |
| Q34416243 | A journey in science: medical scientist in translation |
| Q32059746 | A novel role of Sp1 and Sp3 in the interferon-gamma -mediated suppression of macrophage lipoprotein lipase gene transcription. |
| Q38737500 | ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis |
| Q33269201 | Accumulation of immune cells and high expression of chemokines/chemokine receptors in the upstream shoulder of atherosclerotic carotid plaques |
| Q68943921 | An immunohistochemical analysis of human aortic fatty streaks |
| Q37141880 | Analysis of adhesion molecules in the immunopathogenesis of giant cell arteritis |
| Q38349757 | Anti-inflammatory therapies for atherosclerosis |
| Q55403025 | Atherosclerosis as autoimmune disease. |
| Q73740656 | Atherosclerosis of the liver allograft |
| Q36583651 | Atherosclerosis: immune and inflammatory aspects |
| Q35787847 | CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells |
| Q35538118 | CD4+ T cells in atherosclerosis |
| Q36333439 | Cells, cytokines and cellular immunity in the pathogenesis of fibroproliferative vasculopathies |
| Q68749216 | Cellular and immunologic features of carotid artery disease in man and experimental animal models |
| Q68894332 | Class II MHC antigen expression in the atherosclerotic plaque: smooth muscle cells express HLA-DR, HLA-DQ and the invariant gamma chain |
| Q77098119 | Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation |
| Q33564406 | Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury |
| Q54200968 | Cyclosporine A Inhibits Induction of DNA Synthesis by PDGF and Other Peptide Mitogens in Cultured Rat Aortic Smooth Muscle Cells and Dermal Fibroblasts |
| Q60746676 | Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines |
| Q69618965 | Cytoskeletal features of normal and atheromatous human arterial smooth muscle cells |
| Q33848520 | Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions |
| Q34979474 | Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis |
| Q35817589 | Detection of activated T lymphocytes in the human atherosclerotic plaque |
| Q28214364 | Effects of VasoCare therapy on the initiation and progression of atherosclerosis |
| Q45790640 | Endothelial MHC class II antigen expression and endarteritis associated with Marek's disease virus infection in chickens |
| Q36256278 | Endothelial function and inflammation in coronary artery disease |
| Q42481055 | Endothelin and eicosanoid synthesis in cultured mesangial cells |
| Q37257235 | Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques |
| Q42803118 | Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice |
| Q26748661 | Excessive intimal hyperplasia in human coronary arteries before intimal lipid depositions is the initiation of coronary atherosclerosis and constitutes a therapeutic target |
| Q38107072 | Free radicals and endothelial dysfunction: potential positive effects of TNF-α inhibitors. |
| Q90181222 | From Focal Lipid Storage to Systemic Inflammation: JACC Review Topic of the Week |
| Q33762089 | Functionality of specific immunity in atherosclerosis |
| Q35746446 | Generation of C-reactive protein and complement components in atherosclerotic plaques |
| Q43819617 | HLA-DR expression in the vascular lesion and circulating T lymphocytes of patients with giant cell arteritis |
| Q35523321 | Helper T cells and atherosclerosis: the cytokine web |
| Q68095509 | Heparan sulfate-degrading enzymes induce modulation of smooth muscle phenotype |
| Q41821849 | Heparin as a Therapy for Atherosclerosis: Preliminary Observations on the Intrapulmonary Administration of Low-Dose Heparin in the Morning Versus Evening Gauged by Its Effect on Blood Variables |
| Q40628941 | Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity |
| Q35811302 | Heterogeneity of smooth muscle cells in atheromatous plaque of human aorta |
| Q64898893 | How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses. |
| Q42773864 | Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response |
| Q36352574 | Human interleukin 1 induces interleukin 1 gene expression in human vascular smooth muscle cells |
| Q37368296 | IFN-gamma potentiates atherosclerosis in ApoE knock-out mice |
| Q24815311 | Identification, structural, and functional characterization of a new early gene (6A3-5, 7 kb): implication in the proliferation and differentiation of smooth muscle cells |
| Q40872807 | Immune and inflammatory mechanisms in the development of atherosclerosis |
| Q37150605 | Immune effector mechanisms implicated in atherosclerosis: from mice to humans |
| Q40696369 | Immune mechanisms in atherogenesis |
| Q34737721 | Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis |
| Q73914311 | Immunization with homologous oxidized low density lipoprotein reduces neointimal formation after balloon injury in hypercholesterolemic rabbits |
| Q35833004 | Immunology of atherosclerosis. Demonstration of heat shock protein 60 expression and T lymphocytes bearing alpha/beta or gamma/delta receptor in human atherosclerotic lesions. |
| Q41029708 | Immunology of atherosclerosis: the promise of mouse models. |
| Q35753555 | Immunomodulation and vaccination for atherosclerosis |
| Q33890414 | Immunomodulation of atherosclerosis: myth and reality. |
| Q37484780 | Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease |
| Q38083555 | Inflammation and immune system interactions in atherosclerosis |
| Q35813657 | Inflammation in atherosclerosis and diabetes mellitus |
| Q57797462 | Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week |
| Q33805176 | Inflammatory and autoimmune reactions in atherosclerosis and vaccine design informatics |
| Q34428150 | Inflammatory pathways in atherosclerosis and acute coronary syndromes |
| Q77073443 | Influence of FK506 on experimental atherosclerosis in cholesterol-fed rabbits |
| Q34145731 | Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation. Participation of tryptophan metabolism along the kynurenine pathway |
| Q83005979 | Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome |
| Q36356932 | Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells |
| Q24289002 | Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells |
| Q41019669 | Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages |
| Q33592542 | Is extravasation a Fas-regulated process? |
| Q37307983 | Is hypertension an immunologic disease? |
| Q35713532 | Linking immunity to atherosclerosis: implications for vascular pharmacology--a tribute to Göran K. Hansson |
| Q73589929 | Lipoprotein(a) and HLA-DRB1 and -DQB1 genes in coronary artery disease |
| Q35597306 | MHC Class II-restricted antigen presentation by plasmacytoid dendritic cells drives proatherogenic T cell immunity |
| Q42477839 | MHC class II antigen expression in human vascular smooth muscle cells is induced by interferon-gamma and modulated by tumour necrosis factor and lymphotoxin |
| Q28075968 | Metainflammation in Diabetic Coronary Artery Disease: Emerging Role of Innate and Adaptive Immune Responses |
| Q73918135 | Monocytes influence the fate of T cells challenged with oxidised low density lipoproteins towards apoptosis or MHC-restricted proliferation |
| Q36302873 | NADPH oxidases: an overview from structure to innate immunity-associated pathologies |
| Q37893442 | Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease |
| Q42791983 | Oxidative stress in cardiovascular inflammation: its involvement in autoimmune responses |
| Q37612342 | P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall. |
| Q39862365 | PPARgamma enhances IFNgamma-mediated transcription and rescues the TGFbeta antagonism by stimulating CIITA in vascular smooth muscle cells |
| Q35587171 | Peroxisome proliferator-activated receptor-γ agonists in atherosclerosis: current evidence and future directions |
| Q74438950 | Plaque burden, arterial remodeling and plaque vulnerability: determined by systemic factors? |
| Q36586196 | Potential role of dendritic cells for progression of atherosclerotic lesions |
| Q41755325 | Pretreatment of human vascular smooth muscle cells with interleukin-1 enhances interleukin-6 production and cell proliferation (action of IL-1 on vascular smooth muscle cells). |
| Q34244878 | Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6. |
| Q42415505 | Quantification of Various Inflammatory Cells in Advanced Atherosclerotic Plaques |
| Q38774904 | Readapting the adaptive immune response - therapeutic strategies for atherosclerosis |
| Q37666992 | Regulation of high-density lipoprotein by inflammatory cytokines: establishing links between immune dysfunction and cardiovascular disease |
| Q34193476 | Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines |
| Q38620803 | Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential. |
| Q36427699 | Role of dendritic cells in atherosclerosis |
| Q35833262 | Rous-Whipple Award Lecture. Atherosclerosis: a defense mechanism gone awry. |
| Q40799447 | Synergistic transcriptional activation of human Acyl-coenzyme A: cholesterol acyltransterase-1 gene by interferon-gamma and all-trans-retinoic acid THP-1 cells |
| Q35830485 | Synthesis of IL-1 alpha and IL-1 beta by arterial cells in atherosclerosis |
| Q33560535 | T cell subsets and expression of immunological activation markers in the arterial walls of patients with giant cell arteritis |
| Q34336323 | T cells in vascular inflammatory diseases |
| Q34390132 | T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein |
| Q37629703 | T lymphocytes inhibit the vascular response to injury |
| Q47912776 | T-lymphocytes and monocytes in atherogenesis |
| Q42478982 | The effect of tyrphostin AG-556 on intimal thickening in a mouse model of arterial injury |
| Q36508676 | The immune response in atherosclerosis: a double-edged sword |
| Q39230390 | The immunology of atherosclerosis |
| Q39691796 | The nature of atheroma |
| Q27000791 | The role of T and B cells in human atherosclerosis and atherothrombosis |
| Q35792034 | The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice |
| Q35692035 | Vaccination and atherosclerosis |
Search more.